Literature DB >> 3337276

Self-care capacity and anticholinergic drug levels in nursing home patients.

B W Rovner1, A David, M J Lucas-Blaustein, B Conklin, L Filipp, L Tune.   

Abstract

The serum anticholinergic levels of 22 demented nursing home patients were related to their cognition and capacity for self-care. The patients with high anticholinergic levels had greater impairment in self-care capacity than patients with low levels.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3337276     DOI： 10.1176/ajp.145.1.107

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  10 in total

1.  Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.

Authors:  Hege Kersten; Espen Molden; Tiril Willumsen; Knut Engedal; Torgeir Bruun Wyller
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Central Anticholinergic Adverse Effects and Their Measurement.

Authors:  Pasi Lampela; Teemu Paajanen; Sirpa Hartikainen; Risto Huupponen
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 3.  Drug-induced dementia. Incidence, management and prevention.

Authors:  J M Starr; L J Whalley
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

Review 4.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.

Authors:  Pasi Lampela; Piia Lavikainen; J Arturo Garcia-Horsman; J Simon Bell; Risto Huupponen; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

6.  Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study.

Authors:  Sujita W Narayan; Sarah N Hilmer; Simon Horsburgh; Prasad S Nishtala
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

Review 7.  The cognitive impact of anticholinergics: a clinical review.

Authors:  Noll Campbell; Malaz Boustani; Tony Limbil; Carol Ott; Chris Fox; Ian Maidment; Cathy C Schubert; Stephanie Munger; Donna Fick; David Miller; Rajesh Gulati
Journal:  Clin Interv Aging       Date:  2009-06-09       Impact factor: 4.458

8.  Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium.

Authors:  Christine Thomas; Ute Hestermann; Juergen Kopitz; Konstanze Plaschke; Peter Oster; Martin Driessen; Christoph Mundt; Matthias Weisbrod
Journal:  BMC Neurosci       Date:  2008-09-15       Impact factor: 3.288

Review 9.  Serum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer's disease.

Authors:  Koji Hori; Kimiko Konishi; Masayuki Tani; Hiroi Tomioka; Ryo Akita; Yuka Kitajima; Mari Aoki; Sachiko Yokoyama; Kazunari Azuma; Daisuke Ikuse; Norihisa Akashi; Misa Hosoi; Koichi Jinbo; Mitsugu Hachisu
Journal:  Dis Markers       Date:  2014-02-09       Impact factor: 3.434

Review 10.  Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature.

Authors:  Mohammed Saji Salahudeen; Te-Yuan Chyou; Prasad S Nishtala
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.